NovoCure Limited (NVCR)
NASDAQ: NVCR · Real-Time Price · USD
17.71
-0.17 (-0.95%)
At close: Jul 3, 2025, 1:00 PM
17.60
-0.11 (-0.61%)
After-hours: Jul 3, 2025, 3:10 PM EDT
NovoCure Employees
NovoCure had 1,488 employees as of December 31, 2024. The number of employees increased by 35 or 2.41% compared to the previous year.
Employees
1,488
Change (1Y)
35
Growth (1Y)
2.41%
Revenue / Employee
$417,817
Profits / Employee
-$110,340
Market Cap
1.97B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
NVCR News
- 4 days ago - Novocure to Present Final Secondary Endpoint Data from the Phase 3 PANOVA-3 Trial of Tumor Treating Fields (TTFields) in Pancreatic Cancer at the ESMO Gastrointestinal Cancers Congress 2025 - Business Wire
- 5 days ago - Novocure to Report Second Quarter 2025 Financial Results - Business Wire
- 4 weeks ago - NovoCure's Tumor Treating Fields Boost One-Year And Pain-Free Survival In Pancreatic Cancer Trial - Benzinga
- 5 weeks ago - Zai Lab and Novocure Announce Results From the Phase 3 PANOVA-3 Trial of Tumor Treating Fields (TTFields) Therapy for Pancreatic Cancer to be Presented at 2025 ASCO Annual Meeting - Business Wire
- 5 weeks ago - Results From the Phase 3 PANOVA-3 Trial of Novocure's Tumor Treating Fields (TTFields) Therapy for Pancreatic Cancer to be Presented at 2025 ASCO Annual Meeting - Business Wire
- 5 weeks ago - Novocure Announces Upcoming Investor Events - Business Wire
- 6 weeks ago - NovoCure: Loading Up On Growth Catalysts - Seeking Alpha
- 2 months ago - NovoCure Warns Of Potential $11 Million Tariff Hit If US Trade Pause Expires In 2025 - Benzinga